Target intelligence / Profile preview

Mannosidase alpha class 1A member 1 (MAN1A1)

Target
MAN1A1
Molecular classification
Enzyme, Glycosyl hydrolase
01

Overview

Mannosidase alpha class 1A member 1 (MAN1A1) is a Golgi-localized enzyme belonging to the glycosyl hydrolase 47 family, primarily responsible for the early stages of N-glycan processing [UniProt: P33907]. It specifically catalyzes the removal of alpha-1,2-linked mannose residues from Man9GlcNAc2 to produce Man6GlcNAc2, a critical step for the subsequent synthesis of complex and hybrid N-glycans [NCBI Gene: 4121]. In oncology, MAN1A1 is recognized for its role in regulating the glyco-checkpoint; its downregulation is frequently observed in aggressive cancers like breast and hepatocellular carcinoma, leading to an accumulation of high-mannose glycans that promote tumor cell migration and immune evasion [PMID: 29453315, PMID: 24607494]. While small molecule inhibitors such as kifunensine are widely used in research to block this pathway, therapeutic strategies targeting MAN1A1 mRNA via RNA interference (RNAi) or antisense oligonucleotides are being explored to modulate glycan-dependent signaling in the tumor microenvironment [PMID: 31515460]. Understanding the balance of MAN1A1 activity is crucial, as its dysregulation significantly impacts the stability and function of various cell surface receptors, including integrins and growth factor receptors [PMID: 25666607]. Furthermore, MAN1A1 expression levels serve as potential prognostic biomarkers in several malignancies, reflecting the metabolic state of the cell's glycosylation machinery.

Other names
Alpha-1,2-mannosidase IAMannosyl-oligosaccharide 1,2-alpha-mannosidase IAHUMM3HUMM9
02

Mechanism of action

Inhibition of alpha-1,2-mannosidase activity or reduction of MAN1A1 expression to modulate N-glycan maturation and cell surface glycan profiles.

03

Biological functions

Protein glycosylationN-glycan processingMannose trimming
04

Disease associations

CancerMetastasis
05

Safety considerations

Systemic disruption of N-glycan processingPotential for pleiotropic effects on multiple glycoproteins
06

Interacting drugs

Kifunensine

1 more in the full profile.

07

Biomarkers

MAN1A1 mRNA expression levelsHigh-mannose glycan abundance

Beyond the preview

Go deeper on Mannosidase alpha class 1A member 1 (MAN1A1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mannosidase alpha class 1A member 1 (MAN1A1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call